Finanzdaten der Neuropace Inc-Aktie (NPCE)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 3.43%22.83 | 22.07 | 26.59 | 27.35 | 23.52 |
| Cost Of Revenue | 2.49%3.92 | 4.02 | 6.01 | 6.19 | 5.39 |
| Gross Profit | 4.75%18.91 | 18.05 | 20.58 | 21.17 | 18.13 |
1.83%24.05 | 23.62 | 22.35 | 23.77 | 24.96 | |
| Research and Development | 4.05%6.90 | 7.19 | 7.03 | 6.58 | 6.85 |
| Operating Income/Loss | 7.63%-5.14 | -5.57 | -1.77 | -2.60 | -6.82 |
| Income/Loss From Continuing Operations After Tax | -6.20 | - | -2.73 | -3.50 | -8.65 |
| Income/Loss From Discontinued Operations, Net Of Tax | - | - | - | - | - |
7.31%-6.20 | -6.69 | -2.73 | -3.50 | -8.65 | |
| Attributable To Parent | 7.31%-6.20 | -6.69 | -2.73 | -3.50 | -8.65 |
| Basic Average Shares | 1.15%34.10 | 33.72 | 0.22 | 33.13 | 32.86 |
| Diluted Average Shares | 1.15%34.10 | 33.72 | 0.22 | 33.13 | 32.86 |
| Basic Earnings Per Share | 10.00%-0.18 | -0.20 | -0.08 | -0.11 | -0.26 |
| Diluted Earnings Per Share | 10.00%-0.18 | -0.20 | -0.08 | -0.11 | -0.26 |
| Common Stock Dividends | - | - | - | - | - |